Risk Versus Reward: The Value of
Cell Therapy for Patients and Investors Source: Streetwise Reports (4/25/18) The cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage developm
Cell Therapy for Patients and Investors Source: Streetwise Reports (4/25/18) The cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage devel
Therapy for Patients
and Investors Source: Streetwise Reports (4/25/18) The
cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage developm
cell therapy space, encompassing disruptive new treatment including stem cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage devel
therapy space, encompassing disruptive new treatment including stem
cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage developm
cell therapy, immunotherapy and gene editing, has begun to mature, with a handful of product approvals and others in late - stage devel
therapy, immunotherapy
and gene editing, has
begun to mature, with a handful of product approvals
and others in late - stage development.
Robert Beall becomes CEO of the CFF
and, grasping the limitations of
gene therapy, invests $ 3.2 million in Aurora Biosciences Corp., where
cell physiologist Paul Negulescu
begins to look for a chemical cure using high - throughput methods to test large numbers of potential drugs.
«Assuming they do get going, we will look back
and think that this is the real
beginning of
gene therapy,» said Robin Lovell - Badge, PhD, Group Leader
and Head of Steam
Cell Biology
and Developmental Genetics at the Francis Crick Institute in London.